Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

NovaBay Pharmaceuticals (NBY) Short-Term Debt issuances (2022)

Historic Short-Term Debt issuances for NovaBay Pharmaceuticals (NBY) over the last 4 years, with Q1 2022 value amounting to -$105000.0.

  • NovaBay Pharmaceuticals' Short-Term Debt issuances changed N/A to -$105000.0 in Q1 2022 from the same period last year, while for Dec 2022 it was -$105000.0, marking a year-over-year change of. This contributed to the annual value of -$105000.0 for FY2022, which is 20000.0% down from last year.
  • Per NovaBay Pharmaceuticals' latest filing, its Short-Term Debt issuances stood at -$105000.0 for Q1 2022.
  • NovaBay Pharmaceuticals' Short-Term Debt issuances' 5-year high stood at -$105000.0 during Q1 2022, with a 5-year trough of -$105000.0 in Q1 2022.